# OnCo record actg-a5263 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/actg-a5263/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "actg-a5263", "NCT01435018" ;
  schema:name "ACTG A5263/AMC 066"@en ;
  schema:alternateName "ACTG A5263"@en, "A5263"@en, "AMC 066"@en ;
  schema:description "ACTG A5263 tested whether two cheaper, easier chemotherapies could replace paclitaxel for people with HIV and advanced Kaposi sarcoma in Africa; both were clearly worse, so paclitaxel with antiretroviral therapy is the treatment to aim for wherever it can be supplied."@en ;
  schema:url <https://onco.cc/trials/actg-a5263/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01435018> ;
  onco:status "positive" ;
  onco:tag "soc-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/kaposi-sarcoma/>, <https://onco.cc/cancers/vascular-tumours/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/bleomycin/>, <https://onco.cc/drugs/vincristine/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-actg-a5263-kaposi-sarcoma-resource-limited-krown-lancet-2020/> .